Get started
Author

Kees van Grootheest

Observed names: Grootheest, Kees Van, K Van Grootheest, K. Van Grootheest, Kees Grootheest, Kees K van Grootheest, Kees Van Grootheest, Van Grootheest, Kees, van Grootheest K, van Grootheest, K., van Grootheest, Kees
OpenAlex ID: A5020000643
Adverse Drug Reaction-Related Hospitalisations
2006 · Cornelis S van der Hooft, Miriam C J M Sturkenboom, et al. · Drug Safety · 189
Adverse Drug Reaction Reporting by Patients in the Netherlands
2008 · Joyce de Langen, Florence van Hunsel, et al. · Drug Safety · 177
Pharmacists' role in reporting adverse drug reactions in an international perspective
2003 · Kees van Grootheest, Sten Olsson, et al. · Pharmacoepidemiology and Drug Safety · 170
Experiences with Adverse Drug Reaction Reporting by Patients
2011 · Florence van Hunsel, Linda Härmark, et al. · Drug Safety · 153
PDF
Application of Quantitative Signal Detection in the Dutch Spontaneous Reporting System for Adverse Drug Reactions
2003 · Eug??ne P van Puijenbroek, Willem L Diemont, et al. · Drug Safety · 148
Consumer Adverse Drug Reaction Reporting
2003 · Kees van Grootheest, Linda de Graaf, et al. · Drug Safety · 115
Adverse drug reaction reports of patients and healthcare professionals—differences in reported information
2014 · Leàn Rolfes, Florence van Hunsel, et al. · Pharmacoepidemiology and Drug Safety · 88
PDF
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example
2009 · Florence Van Hunsel, Anneke Passier, et al. · British Journal of Clinical Pharmacology · 87
PDF
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
2010 · Florence van Hunsel, Christine van der Welle, et al. · European Journal of Clinical Pharmacology · 86
PDF
Patients’ role in reporting adverse drug reactions
2004 · Kees van Grootheest, Lolkje de Jong-van den Berg · Expert Opinion on Drug Safety · 74
Determinants of signal selection in a spontaneous reporting system for adverse drug reactions
2001 · Eugène P. Van Puijenbroek, Kees Van Grootheest, et al. · British Journal of Clinical Pharmacology · 69
PDF
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case–control study
2010 · Florence van Hunsel, Attje Talsma, et al. · Pharmacoepidemiology and Drug Safety · 54
Thromboembolism associated with the new contraceptive Yasmin
2003 · Kees van Grootheest, Tom Vrieling · BMJ · 53
PDF
The rosiglitazone decision process at FDA and EMA. What should we learn?
2012 · Koen B. Pouwels, Kees van Grootheest · International Journal of Risk & Safety in Medicine · 48
Uterine Perforation with the Levonorgestrel-Releasing Intrauterine Device
2010 · Kees van Grootheest, Bernhardt Sachs, et al. · Drug Safety · 39
Reporting of Adverse Drug Reactions by General Practitioners
2009 · Anneke Passier, Marije ten Napel, et al. · Drug Safety · 38
Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study
2012 · Anke A G Posthumus, Carien C W Alingh, et al. · BMJ Open · 37
PDF
Intensive Monitoring of Pregabalin
2011 · Linda Härmark, Eugène van Puijenbroek, et al. · Drug Safety · 35
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins
2009 · Florence van Hunsel, Eugène van Puijenbroek, et al. · Pharmacoepidemiology and Drug Safety · 32
Longitudinal monitoring of the safety of drugs by using a web‐based system: the case of pregabalin
2011 · Linda Härmark, Eugene van Puijenbroek, et al. · Pharmacoepidemiology and Drug Safety · 31
Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring
2011 · Linda Härmark, Florence van Hunsel, et al. · Vaccine · 31
Important information regarding reporting of adverse drug reactions: a qualitative study
2013 · Leàn Rolfes, Sarah Wilkes, et al. · International Journal of Pharmacy Practice · 30
Patients’ motives for participating in active post‐marketing surveillance
2012 · Linda Härmark, Miguel Lie‐Kwie, et al. · Pharmacoepidemiology and Drug Safety · 29
Web-based intensive monitoring: from passive to active drug surveillance
2011 · Linda Härmark, Kees van Grootheest · Expert Opinion on Drug Safety · 29
The Dawn of Pharmacovigilance
2003 · Kees van Grootheest · International Journal of Pharmaceutical Medicine · 29
Works count: 65
Citation count: 2,122
H-index: 26
I10-index: 37
Year
Topic
Type